ADVANCE infectious diseases pharmacy and LEAD antimicrobial stewardship in order
to OPTIMIZE the care of patients
The SIDP Programs Committee and Board of Directors are excited to announce Dr. Ilisa Bernstein, PharmD, JD, FAPhA, Interim CEO and Executive Vice President of the American Pharmacists Association (APhA) as the keynote speaker for the 2022 Annual Business Meeting. Dr. Bernstein will present, “A Seat at the Table: Advocating for ID Pharmacy.”
The business meeting will be held at the Walter E. Washington Convention Center in Washington D.C from 2:30-6 p.m. EST on October 18, 2022, one day prior to the start of the live IDWeekTM 2022 meeting. A reception with socialization, light appetizers, and beverages will immediately follow the business meeting from 6-9 p.m. EST. More information can be found at SIDP - Annual Meetings.
Additionally, we are pleased to announce a virtual option to attend the business meeting for those who are unable to attend in person. Please visit SIDP - 2022 SIDP Annual Business Meeting and Reception to register as a virtual attendee prior to October 18, 2022.
SIDP is assisting the Society for Healthcare Epidemiology of America (SHEA) in identifying nominations for an associate editor for the Antimicrobial Stewardship and Healthcare Epidemiology (ASHE) journal.
SIDP is proposing the appointment of an SIDP member who is middle or advanced career for this position. ASHE focuses on practice-based, clinical research, including antimicrobial stewardship, prevention of healthcare-associated infections, and other areas of quality improvement affecting health systems, with the goal of improving healthcare safety. The associate editor, if appointed, should have clinical and research experience, specifically in this space.
SIDP will forward the name of the recommended candidate to the Editor-in-Chief (EIC) of ASHE for consideration. The EIC is responsible for appointment of the associate editor, the name of whom is then submitted to the SHEA Board of Directors to be ratified.
Interested members should submit a statement of interest, CV, and three blinded peer reviews by Friday, June 24, 2021. Blinded peer reviews should only contain the feedback sent and not the original manuscript; author and title names should be struck from submitted documents. The committee will evaluate candidates' publication record in peer-reviewed journals and peer review experience. The number of peer reviews completed and a list of journals by name for whom the candidate has reviewed papers in the last 2 years should be clearly available in either the CV or statement of interest.
SIDP, SHEA, and ASHE are committed to represent diverse interests and viewpoints. We encourage candidates to share any unique perspectives they have that would facilitate their role and expand the purview of ASHE.
Interested candidates should submit their application materials and any questions to the Chair of Publications and Podcasts committee, Rachel Britt, email@example.com.
Candidate Scoring Guide
Diverse representation - geographic (i.e., resource-limited practice), work with special populations, candidate part of minoritized community or group (including but not limited to LGBTIQA+, race/ethnicity, gender), unique or significant service
6 points for applicant’s practice; 4 points for applicant
Experienced reviewer for significant journals (in the past 2 years since Jan 2020)
Research – CID, OFID, JAC, AAC, ICHE
Education – AJPE, AM, ME, ASHE
Members of the SIDP Public Outreach Committee recently published an editorial in the Journal of the American College of Clinical Pharmacy on pharmacists’ role in antimicrobial stewardship (ASP) interventional research.
Most healthcare institutions in the U.S. rely on pharmacy services to develop and expand ASP initiatives. In 2019, members of the committee sought to characterize trends in ASP interventional research. Using PubMed to identify studies evaluating the impact of an ASP intervention from 1990-2019 in North America, SIDP found that the frequency of pharmacist authorship has been increasing over the last twenty years. Overall, two-thirds of publications included a pharmacist as an author. A subset of one-hundred studies was further reviewed for intervention type, outcomes of interest, study setting, population, and descriptive methodology. The findings of this report informed the following recommendations and opportunities for expansion in ASP interventional research:
The second annual Infectious Diseases Pharmacists Day will be held on Sunday, May 22, 2022. This day recognizes the importance of ID pharmacists in promoting appropriate antimicrobial use and the contributions they make to patient care, education, and research. This year’s theme is deprescribing antibiotics in COVID-19. Please check out the SIDP - Infectious Diseases Pharmacists Day website for opportunities to show your support, including a Twitter Storm, access to the Advocacy tool kit, and Share Your Story to be featured on our social media pages. We look forward to an exciting virtual turn out!
On Behalf of the SIDP Nominations and Bylaws Committee
Chair: Wes Kufel
Vice Chair: Lindsey Childs-Kean
Immediate Past-Chair: Cynthia Nguyen
Board Liaison: Jason Pogue
Committee Members: Karrine Brade, Monica Mahoney, Lee Nguyen, Katie Parsels, Brian Potoski, Melissa Steenhoek
Please consider nominating either a colleague or yourself for an SIDP Recognition Award, to be given at the SIDP Business and Lecture Series this fall. Each year, the Society recognizes the excellence of its members with the Young Investigator of the Year, Pharmacotherapy Paper of the Year, Clinician of the Year, and Gita Patel Best Practice Award. In addition, a Distinguished Service Award may be awarded by the Society to recognize truly outstanding and lasting service (this award is not necessarily given annually).
Nominations need to be received by Monday, April 12, 2021. Supporting materials for each nominee will be due Monday, May 17, 2021. Winners will be notified no later than Monday, June 21, 2021 for Clinician of the Year and Friday, July 30, 2021 for other Recognition Awards.
All nominations and supporting materials can be sent to Kate DeSear (firstname.lastname@example.org) and Shelley Warnock (email@example.com).
Each award description, criteria, and required supporting materials are detailed on the website via the following link: SIDP Recognition Awards.
Please consider your deserving colleagues or yourself for these awards!
The SIDP Recognition Awards Committee
The Society of Infectious Diseases Pharmacists (SIDP) is pleased to solicit nominations for Fellowship in SIDP (FIDP). The Fellowship distinction was developed to recognize outstanding SIDP members who have made a significant and sustained contribution to the area of infectious diseases and the mission of SIDP. Successful applicants for Fellowship in SIDP demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy.
Please consider nominating a colleague for this award, to be given at the SIDP Business Meeting and Lecture Series this fall. Further information regarding the nomination and application process is provided below.
Minimum Eligibility Criteria
Nominees for FIDP must meet all of the following criteria:
1. Be a current active member of SIDP
2. Have been in practice in the field of infectious diseases for at least 10 years since receipt of terminal training (not including residency or fellowship)
3. Have made sustained contributions to SIDP as detailed in the evaluation criteria
4. Be present at the SIDP Business Meeting to be recognized.
*Note: Current SIDP board members or Recognition Awards Committee members are ineligible for nomination
In order to be considered for distinction, an initial nomination in the form of a letter from an active member of SIDP is required. The nomination letter should be submitted via email to the Chair of the Recognition Awards Committee, Kate DeSear (firstname.lastname@example.org). The nomination letter should outline how the nominee fulfills the eligibility criteria, including a brief description of the nominee’s sustained contributions to SIDP and excellence in the field of infectious diseases through practice, education, scholarship, etc. The nomination letter should also include the nominee’s current email and phone number. Nominations will be accepted annually. The deadline for nominations this cycle is Monday, April 12, 2021.
Nominees fulfilling minimum eligibility requirements will be sent a link to an online application form. The deadline for full applications is Monday, June 14, 2021. Awardees will be notified no later than Friday, August 27, 2021. More details on the application process including a copy of the application and the scoring rubric can be found here.
Please consider your deserving colleagues for this award!
The SIDP Recognition Awards Committee
Congratulations to the Newly Elected SIDP Board Members for 2020–2021!
Board Member-at-LargeMeghan Jeffres
The SIDP Board of Directors and Nominations and Bylaws Committee would like to thank all of the extremely qualified members who ran in the 2020 election for President-Elect, Treasurer, and Board Member-at-Large. We appreciate your commitment to SIDP and advancing our profession. Additionally, we would like to thank everyone for participating in the election and to our Website and Social Media Committees for their assistance. Please join us in congratulating these individuals!
Chair: Cynthia Nguyen
Vice Chair: Wesley Kufel
Immediate Past-Chair: Brandon Dionne
Board Liaison: Kerry LaPlante
Committee Members: Karrine Brade, Lindsey Childs-Kean, Monica Mahoney, Brian Potoski, Jenny Shroba, Melissa Steenhoek
Today, the National Institute of Health (NIH) released the COVID-19 treatment guidelines, available at covid19treatmentguidelines.nih.gov. The NIH COVID-19 Treatment Guideline is a living document that will be updated as new information becomes available.
The Society of Infectious Diseases Pharmacists President-Elect Susan Davis represents SIDP on the treatment guideline panel. The panel was convened urgently in late March and includes clinicians with expertise in infectious diseases, critical care, emergency medicine, and pharmacy. Dr. Davis is one of six clinical pharmacists on the panel, joining others from federal agencies and the Society of Critical Care Medicine.
"I'm honored to work with this diverse group of clinicians and scientists on the treatment guidelines panel. The pharmacy team has been working nonstop to critically evaluate emerging literature and provide pharmacotherapy expertise," says Dr. Davis. "These guidelines will provide essential information for healthcare professionals trying to understand the rationale and limitations of proposed COVID-19 therapies."
"We are very pleased to have SIDP represented on the NIH COVID-19 Treatment Guidelines Panel. SIDP members around the country have been working with their colleagues and communities to design local treatment guidelines, facilitate access to therapies, and educate patients and staff. ID pharmacists provide unique expertise and perspective that is crucial during this ongoing pandemic. We applaud the National Institutes of Health for recognizing and seeking out this expertise," said SIDP President Jason Pogue.
Further information from the NIH regarding these guidelines is available here.
Please visit sidp.org/covid19 for additional educational offerings and resources from SIDP related to COVID-19.
Society of Infectious Diseases Pharmacists • 403 W. Saint Charles, Suite B, Lombard, IL 60148
(331) 248-7888 • email@example.com
Proudly Managed by Affinity Strategies